Go to the profile of Aeglea Biotherapeutics

Aeglea Biotherapeutics

 
  • United States of America

About Aeglea Biotherapeutics

Aeglea BioTherapeutics was founded in December 2013 to develop engineered human enzymes invented in the laboratory of George Georgiou, Ph.D. of The University of Texas at Austin. The convergence of discovery and technology has created a significant opportunity for Aeglea to potentially impact both the treatment of inborn errors of metabolism and cancer.

Therapeutic Areas

Metabolic Oncology

Technologies

Diagnostics

Company Type

Biotechnology – Therapeutics

State of Ownership

Private

Influencer Of

Topics

Topics contributed to:

Oncology

Editions participated in:

June 2016 June 2017